stella
beta
Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES) — Stella
Recruiting
Back to Advanced Breast Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Peking Union Medical College Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov